Morrison Jodie Pope 4
4 · Q32 Bio Inc. · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Q32 Bio (QTTB) CEO Jodie Pope Sells 9,896 Shares
What Happened
- Jodie Pope, CEO and Director of Q32 Bio, sold 9,896 shares in a disposition reported on Form 4. The weighted-average price was $4.51, for total proceeds of about $44,675. The sale was to cover tax withholding obligations related to the vesting of restricted stock units and was automatic, not at the Reporting Person’s discretion.
Key Details
- Transaction date: 2026-02-25; Form 4 filed: 2026-02-27 (appears timely).
- Price: weighted average $4.51; shares sold across prices ranging $4.35–$4.69.
- Total proceeds: ~$44,675.
- Shares owned after the transaction: not specified in the provided filing.
- Footnotes: F1 — sale was automatic to cover tax withholding for RSU vesting; F2 — price is a weighted average and the filer will provide per-price breakdown on request.
- Transaction code: S (sale).
Context
- This was a tax-withholding sale tied to vested RSUs (routine administrative transaction) rather than an open-market discretionary sale intended as a market sentiment signal. Retail investors typically view such withholding-only disposals as ordinary compensation-related transactions, not a direct indicator of management’s view on the stock.
Insider Transaction Report
Form 4
Q32 Bio Inc.QTTB
Morrison Jodie Pope
DirectorCEO
Transactions
- Sale
Common Stock
[F1][F2]2026-02-25$4.51/sh−9,896$44,675→ 89,104 total
Footnotes (2)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.35 to $4.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Signature
/s/ Eric Bell, Attorney-in-Fact|2026-02-27